Philanthropy works best when it backs bold ideas early.

By Ilana Golant, Food Allergy Fund Founder and CEO

February 11, 2026 - The Food Allergy Fund was the earliest supporter of David A. Hill, MD, PhD and The Hill Lab’s work on eosinophilic esophagitis at Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine.

Our early funding helped launch a new blood-based diagnostic approach that could one day spare families from repeated endoscopies and years of trial-and-error diets.

This is the pathway we aim to build: early funding → promising science → clinical validation → better care for patients.

Dr. Hill’s team is now preparing for clinical use—exactly the kind of momentum FAF was built to catalyze.

Read Dr. Hill’s paper which was recently published in Diagnostics.